The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.
Eye (Lond)
; 36(9): 1725-1734, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35314774
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Angiogenesis Inhibitors
/
Wet Macular Degeneration
/
Antibodies, Monoclonal, Humanized
Type of study:
Guideline
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Eye (Lond)
Journal subject:
OFTALMOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom